Product
Supplier
Encyclopedia
Inquiry
Home > News > Policy & Regulation
ECHEMI chemical news

Policy & Regulation

Belgium's Environmental Policies Trigger Turmoil in the European Aromatics Market: Trade Flows Shift Dramatically, Prices Volatile

Belgium's Environmental Policies Trigger Turmoil in the European Aromatics Market: Trade Flows Shift Dramatically, Prices Volatile

2024-10-16

Recently, market observers pointed out that despite Belgium's suspension of low-quality motor fuel exports to West Africa due to environmental disputes, the European aromatics market has not experienced as much volatility as expected.

Chinese Food Products Face Unprecedented Rejection in the US, 913 Batches Banned by FDA Due to Safety Issues!

Chinese Food Products Face Unprecedented Rejection in the US, 913 Batches Banned by FDA Due to Safety Issues!

2024-10-14

According to the United States Food and Drug Administration (FDA) released the third quarter of 2024 (specifically covering July to September) import product rejection report.

Contradictions Between FDA and Hengrui Pharmaceuticals: Behind the Launch of a New Paclitaxel Drug, a Sales Puzzle of 4.3 Billion RMB

Contradictions Between FDA and Hengrui Pharmaceuticals: Behind the Launch of a New Paclitaxel Drug, a Sales Puzzle of 4.3 Billion RMB

2024-10-12

Recently, Hengrui Medicine officially received a notice from the U.S. Food and Drug Administration (FDA) confirming that its abbreviated New Drug Application (ANDA) for paclitaxel for injection (albumin-binding) has been approved.

Pigment Market Hit Hard! Demand Drops by 10%, Supply Chain Risks Intensify, Costs Soar!

Pigment Market Hit Hard! Demand Drops by 10%, Supply Chain Risks Intensify, Costs Soar!

2024-10-11

Market research firm Markets and Markets forecasts that the global pigment market will grow at a compound annual growth rate of 4.5% from now until 2029.

Oxbryta Trial for SCD Patients Reports Death Cases, 8 Out of 236 Participants Die, FDA Urges Not to Discontinue Treatment!

Oxbryta Trial for SCD Patients Reports Death Cases, 8 Out of 236 Participants Die, FDA Urges Not to Discontinue Treatment!

2024-10-09

Doppler ultrasound measurement has a significant impact in medical research. The study focused on clinical data from 236 patients in Egypt, Ghana, Kenya, Nigeria, Oman, Saudi Arabia, the United States and the United Kingdom.

Breakthrough in Schizophrenia Treatment! BMS Acquires Karuna for $14 Billion: New Drug Cobenfy Approved by FDA, Side Effects Only One-Tenth of Old Drugs!

Breakthrough in Schizophrenia Treatment! BMS Acquires Karuna for $14 Billion: New Drug Cobenfy Approved by FDA, Side Effects Only One-Tenth of Old Drugs!

2024-09-27

After decades of stagnation in the field of schizophrenia treatment, Bristol Myers Squibb (BMS) announced the successful acquisition of Karuna Therapeutics for $14 billion.

European Acrylic Market Plunges to the Lowest Point, Building Demand Plummets Over 30%, When Will the Industry's Winter Thaw?

European Acrylic Market Plunges to the Lowest Point, Building Demand Plummets Over 30%, When Will the Industry's Winter Thaw?

2024-09-26

In the current global economic environment, the European acrylic acid market is undergoing a profound transformation.

Austria Revises Food Extract Regulations, MTHF Residue Standards Spark Controversy, Potential Health Risks for Consumers?

Austria Revises Food Extract Regulations, MTHF Residue Standards Spark Controversy, Potential Health Risks for Consumers?

2024-09-24

In the context of the current growing global concern about food safety and consumer health issues, governments are gradually strengthening the regulation of the use of additives and extractants in food production.

Early September Sees Dramatic Changes in Oxygen Market: Supply Chain Disruptions, PMI Decline, Surge in Winter Coal Demand, China Faces Unprecedented Challenges!

Early September Sees Dramatic Changes in Oxygen Market: Supply Chain Disruptions, PMI Decline, Surge in Winter Coal Demand, China Faces Unprecedented Challenges!

2024-09-24

Since the beginning of September, China's oxygen market has experienced unprecedented volatility, mainly due to logistical difficulties, which have brought unprecedented challenges to oxygen production.

New REACH measures restrict PFAS subclass PFHxA

New REACH measures restrict PFAS subclass PFHxA

2024-09-24

The European Commission has announced that it will restrict the use of “subclasses” of per- and polyfluoroalkyl substances (PFAS), so-called “persistent pollutants”.

$135.4 Billion! China’s New Ship Orders Surge 58%, Reaching a 15-Year High!

$135.4 Billion! China’s New Ship Orders Surge 58%, Reaching a 15-Year High!

2024-09-23

China's 10,000 CGT new ship orders increased 27% year-on-year to 135.4 billion US dollars, far exceeding the same period last year's 128.5 billion US dollars, setting a new record.

New Import and Export Food Inspection Regulations Issued: Global Food Safety Faces Severe Challenges!

New Import and Export Food Inspection Regulations Issued: Global Food Safety Faces Severe Challenges!

2024-09-23

On 16-20 September 2024, the Codex Alimentarius Commission (CAC) hosted the 27th Session of the Committee on Import and Export Inspection and Certification (CCFICS 27) in Australia.

PVC Market Struggles in 'Golden September': Prices Plummet Amid Oversupply and Weak Demand, Market Outlook Grim

PVC Market Struggles in 'Golden September': Prices Plummet Amid Oversupply and Weak Demand, Market Outlook Grim

2024-09-20

The performance of terminal demand is weak, the sales of downstream products enterprises are poor, the new orders are insufficient, and the inventory is gradually accumulated, which reduces the willingness of enterprises to stock raw materials.

FDA Shocking Approval of Kisqali: 25% Increased Recurrence Risk for Early Breast Cancer Patients, Treatment Risks Double?

FDA Shocking Approval of Kisqali: 25% Increased Recurrence Risk for Early Breast Cancer Patients, Treatment Risks Double?

2024-09-20

The benefit of invasive disease-free survival (iDFS) compared to receiving endocrine therapy (ET) alone was consistently observed in all patient subgroups 3-6.

European Commission Announces Three Major Regulations

European Commission Announces Three Major Regulations

2024-09-19

The European Commission published three regulations on 17 September 2024.

Zantac Cancer Controversy Reignites, Jury Fails to Reach Verdict Again, 70,000 Lawsuits Pending!

Zantac Cancer Controversy Reignites, Jury Fails to Reach Verdict Again, 70,000 Lawsuits Pending!

2024-09-19

A man in Illinois claimed through his legal counsel that he had developed prostate cancer after taking a certain drug.

Mongolia Releases Draft Regulations on Wheat Flour, 15-Day Feedback Period Sparks Industry Outcry!

Mongolia Releases Draft Regulations on Wheat Flour, 15-Day Feedback Period Sparks Industry Outcry!

2024-09-18

On September 10, 2024, the Mongolian Bureau of Standards and Metrology officially issued a draft standard on wheat flour storage and transportation, and the feedback deadline is set for October 10, 2024.

Rosemary Oil For Hair Growth | Detailed Explanation

Rosemary Oil For Hair Growth | Detailed Explanation

2024-09-14

Hair reflects the health situation of the body. A person normally loses 50-100 hairs per day. How to protect our hair? Today we will discuss the function of rosemary oil for hair growth

China Accelerates Global Pharmaceutical Companies' Entry! China's NMPA Promotes New Drug Approval and International Trade Policies

China Accelerates Global Pharmaceutical Companies' Entry! China's NMPA Promotes New Drug Approval and International Trade Policies

2024-09-13

On September 13, Li Li, director of the State Medical Products Administration, made clear his support for open cooperation in the pharmaceutical industry at a high-profile press conference.

New EU Regulations Approve Multiple Feed Additives, Authorization Period Until 2034

New EU Regulations Approve Multiple Feed Additives, Authorization Period Until 2034

2024-09-12

On September 10, 2024, the European Commission issued a number of regulations relating to the approval and extension of the authorisation period for animal feed additives.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.